Literature DB >> 25510267

When cancer and immunology meet.

Martin Carroll1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25510267      PMCID： PMC4270086          DOI： 10.1111/imr.12250

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  31 in total

1.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

Review 2.  The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled.

Authors:  Michael J Osborne; Katherine L B Borden
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

Review 3.  Epigenetics in T-cell acute lymphoblastic leukemia.

Authors:  Sofie Peirs; Joni Van der Meulen; Inge Van de Walle; Tom Taghon; Frank Speleman; Bruce Poppe; Pieter Van Vlierberghe
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

Review 4.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

Review 5.  Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia.

Authors:  Maike Buchner; Srividya Swaminathan; Zhengshan Chen; Markus Müschen
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

Review 6.  Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

Review 7.  New themes in the biological functions of 5-methylcytosine and 5-hydroxymethylcytosine.

Authors:  Erika L Moen; Christopher J Mariani; Hayley Zullow; Meselle Jeff-Eke; Edward Litwin; John N Nikitas; Lucy A Godley
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

8.  Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.

Authors:  Omar Abdel-Wahab; Ann Mullally; Cyrus Hedvat; Guillermo Garcia-Manero; Jay Patel; Martha Wadleigh; Sebastien Malinge; JinJuan Yao; Outi Kilpivaara; Rukhmi Bhat; Kety Huberman; Sabrena Thomas; Igor Dolgalev; Adriana Heguy; Elisabeth Paietta; Michelle M Le Beau; Miloslav Beran; Martin S Tallman; Benjamin L Ebert; Hagop M Kantarjian; Richard M Stone; D Gary Gilliland; John D Crispino; Ross L Levine
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

9.  Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.

Authors:  Luca Malcovati; Elli Papaemmanuil; Ilaria Ambaglio; Chiara Elena; Anna Gallì; Matteo G Della Porta; Erica Travaglino; Daniela Pietra; Cristiana Pascutto; Marta Ubezio; Elisa Bono; Matteo C Da Vià; Angela Brisci; Francesca Bruno; Laura Cremonesi; Maurizio Ferrari; Emanuela Boveri; Rosangela Invernizzi; Peter J Campbell; Mario Cazzola
Journal:  Blood       Date:  2014-06-26       Impact factor: 22.113

10.  The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

Authors:  Patrick S Ward; Jay Patel; David R Wise; Omar Abdel-Wahab; Bryson D Bennett; Hilary A Coller; Justin R Cross; Valeria R Fantin; Cyrus V Hedvat; Alexander E Perl; Joshua D Rabinowitz; Martin Carroll; Shinsan M Su; Kim A Sharp; Ross L Levine; Craig B Thompson
Journal:  Cancer Cell       Date:  2010-02-18       Impact factor: 38.585
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.